These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7415216)

  • 1. Enzymic formation of dehydrogenated and hydroxylated metabolites from lysergic acid diethylamide by rat liver microsomes.
    Inoue T; Niwaguchi T; Murata T
    Xenobiotica; 1980 May; 10(5):343-8. PubMed ID: 7415216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of inducers and/or inhibitors on metabolism of lysergic acid diethylamide in rat liver microsomes.
    Inoue T; Niwaguchi T; Murata T
    Xenobiotica; 1980 Dec; 10(12):913-20. PubMed ID: 7210704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on enzymatic dealkylation of D-lysergic acid diethylamide (LSD).
    Niwaguchi T; Inoue T; Nakahara Y
    Biochem Pharmacol; 1974 Mar; 23(6):1073-8. PubMed ID: 4151050
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolism of lysergic acid diethylamide (LSD) to 2-oxo-3-hydroxy LSD (O-H-LSD) in human liver microsomes and cryopreserved human hepatocytes.
    Klette KL; Anderson CJ; Poch GK; Nimrod AC; ElSohly MA
    J Anal Toxicol; 2000 Oct; 24(7):550-6. PubMed ID: 11043658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidation of LSD in vitro metabolism by liquid chromatography and capillary electrophoresis coupled with tandem mass spectrometry.
    Cai J; Henion J
    J Anal Toxicol; 1996; 20(1):27-37. PubMed ID: 8837948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of 3-methylcholanthrene and phenobarbitone treatment on the oxidative metabolism of antipyrine in vitro by microsomal fractions of rat liver.
    Kahn GC; Boobis AR; Murray S; Davies DS
    Xenobiotica; 1982 Aug; 12(8):509-16. PubMed ID: 7147996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 enzymes contribute to the metabolism of LSD to nor-LSD and 2-oxo-3-hydroxy-LSD: Implications for clinical LSD use.
    Luethi D; Hoener MC; Krähenbühl S; Liechti ME; Duthaler U
    Biochem Pharmacol; 2019 Jun; 164():129-138. PubMed ID: 30981875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the in vitro metabolism of compounds related to lysergic acid diethylamide (LSD).
    Niwaguchi T; Inoue T; Sakai T
    Biochem Pharmacol; 1974 Nov; 23(21):3063-6. PubMed ID: 4429602
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additional routes in the metabolism of phenacetin.
    Fischbach T; Lenk W
    Xenobiotica; 1985 Feb; 15(2):149-64. PubMed ID: 4002737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of phenobarbital, dexamethasone, and 3-methylcholanthrene administration on the metabolism of 17 beta-estradiol by liver microsomes from female rats.
    Suchar LA; Chang RL; Thomas PE; Rosen RT; Lech J; Conney AH
    Endocrinology; 1996 Feb; 137(2):663-76. PubMed ID: 8593816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotransformation of lovastatin--III. Effect of cimetidine and famotidine on in vitro metabolism of lovastatin by rat and human liver microsomes.
    Vyas KP; Kari PH; Wang RW; Lu AY
    Biochem Pharmacol; 1990 Jan; 39(1):67-73. PubMed ID: 2297361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biphenyl hydroxylations and spectrally apparent interactions with liver microsomes from hamsters pre-treated with phenobarbitone and 3-methylcholanthrene.
    Burke MD; Bridges JW
    Xenobiotica; 1975 Jun; 5(6):357-76. PubMed ID: 238342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolism of lysergic acid DI[14C]ethylamide ([14C]LSD) in the isolated perfused rat liver.
    Siddik ZH; Barnes RD; Dring LG; Smith RL; Williams RT
    Biochem Pharmacol; 1979 Oct; 28(20):3081-91. PubMed ID: 518707
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of the effects of pretreatment with phenobarbitone and 3-methylcholanthrene on the metabolism of aflatoxin B1 by rat liver microsomes and isolated hepatocytes in vitro.
    Metcalfe SA; Colley PJ; Neal GE
    Chem Biol Interact; 1981 May; 35(2):145-57. PubMed ID: 6783328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of phenobarbital and 3-methylcholanthrene induction on the formation of three glucuronide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, NNK.
    Murphy SE; Nunes MG; Hatala MA
    Chem Biol Interact; 1997 Mar; 103(3):153-66. PubMed ID: 9134006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regioselectivity of hydroxylation of prostaglandins by liver microsomes supported by NADPH versus H2O2 in methylcholanthrene-treated and control rats: formation of novel prostaglandin metabolites.
    Holm KA; Engell RJ; Kupfer D
    Arch Biochem Biophys; 1985 Mar; 237(2):477-89. PubMed ID: 3856417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemical study on the route of electron transfer from NADH and NADPH to cytochrome P-450 of liver microsomes.
    Noshiro M; Harada N; Omura T
    J Biochem; 1980 Nov; 88(5):1521-35. PubMed ID: 7462192
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolism of lysergic acid diethylamide (LSD): an update.
    Libânio Osório Marta RF
    Drug Metab Rev; 2019 Aug; 51(3):378-387. PubMed ID: 31266388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsomal metabolism of the carcinogen, N-2-fluorenylacetamide, by the mammary gland and liver of female rats. I. Ring- and N-hydroxylations of N-2-fluorenylacetamide.
    Malejka-Giganti D; Decker RW; Ritter CL; Polovina MR
    Carcinogenesis; 1985 Jan; 6(1):95-103. PubMed ID: 3967341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.